Joint webinar from the UK's drugs regulator MHRA and England's health technology assessment (HTA) body NICE.
It will provide stakeholders with all relevant information about how the MHRA and NICE will collaborate to achieve same time publication, supported by information sharing and joint scientific advice. It will also give stakeholders insight into how to engage with the health system early and highlight key benefits of receiving integrated scientific advice and aligned market authorisation and NICE guidance publication.
Online
Ask for a Free trial and get access to the latest stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
REQUEST
an initial 10 day temporary access of APM Market Access.
